Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination PPI + sodium alginate vs PPI alone in nonerosive reflux disease
KCT0002297Phase 4Completed
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Start
- Jul 2014
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of Sodium alginate in Non-erosive Gastroesophageal Reflux Disease (NERD), sponsored by Taejoon Pharmaceutical Co., Ltd.. Started Jul 2014; status: completed.
02
Drugs
Sodium alginate
03
Conditions
Non-erosive Gastroesophageal Reflux Disease (NERD)
Beyond the preview
Go deeper on KCT0002297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002297.